April 24, 2017

Congress highlights EAS 2017 Prague, Czech Republic

April 23 -26

85th EAS Congress Opens with a light touch of Prague magic!

New EAS President Professor Lale Tokgözoğlu (Hacettepe University, Ankara, Turkey) welcomed all to what promises to be an exciting programme at this year’s Congress. This year’s Congress has broken all past records, with over 2300 delegates attending from across the globe, reaffirming the unique position of EAS at the forefront of research, education and advocacy.

And as EAS Congress Chair Professor Michal Vrablik (Charles University in Prague, Czech Republic) clearly reminded delegates: ‘You are the most important participants at Congress: learn, discuss and most importantly, don’t forget to network!’

2017 Anitschkow Award recipient, Professor Alan Tall (Columbia University, New York, USA) gave an intriguing lecture covering highlights of his research in lipoproteins, including his role in elucidating the part that cholesteryl ester transfer protein (CETP) plays in the regulation of human lipoproteins, providing an impetus to the development of the CETP inhibitors. The development of these agents has, however, followed a rocky road, which may in part relate to off target effects, unanticipated effects on reverse cholesterol transport, as well as underpowered and too short clinical trials. Professor Tall confirmed that the REVEAL (Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification) study with anacetrapib has now been completed and results are anticipated in the summer.

To the full report from the Opening Ceremony and Anitschkow Lecture >>

New EAS Consensus Panel Statement published online today - LDL causes ASCVD

Today the European Atherosclerosis Consensus Panel has published in the European Heart Journal the new Consensus Statement confirming that low-density lipoproteins (LDL) cause atherosclerotic vascular disease. This Statement definitively shows that LDL causes atherosclerotic cardiovascular disease.

Access the Consensus Statement and slides set >>
To the interview with Professor John Chapman, Co-Chair of the Panel >>

Follow the Congress in EAS news feed and social media channels

Find out more

About EAS

EAS Membership

EAS Congress

EAS Educational Initiatives

EAS Publications

European Lipoprotein Club (ELC)

EAS-FH Studies Collaboration (FHSC)

Visit: eas-society.org

About this email

You have received this email because you are currently subscribed to receive general correspondence from EAS.


European Atherosclerosis Society
Mässans Gata 18
Box 5243
SE-402 24, Gothenburg SWEDEN

Organisation number: 802418-0427

This email was sent to '@@email@@' from European Atherosclerosis Society.
If you wish to stop receiving email from us, you can simply remove yourself by visiting: @@unsubscribe_url@@


European Atherosclerosis Society © 2017